Two monoclonal antibodies (mAbs), 10-2 and 10-5, both directed against
recombinant hirudin variant 2-Lys47 (rHV2), were selected for their h
igh affinity and epitopic specificities to develop a two-site immunoas
say of rHV2. The mAb concentrations, incubation time, and temperature
were optimized. The immunoassay has a detection limit for rHV2 of 45 n
g/L in plasma and 30 ng/L in urine. The reactivity of the mAbs was tes
ted against rHV2 and several forms of this protein truncated in the ca
rboxyl terminus. The capture mAb 10-2 was found to be mainly directed
against rHV2, whereas tracer mAb 10-5 was independent of the carboxyl-
terminal region of the protein. This explains the high specificity of
the immunoassay for the 65-amino acid form of hirudin.